Exact Mass: 473.21752720000006

Exact Mass Matches: 473.21752720000006

Found 4 metabolites which its exact mass value is equals to given mass value 473.21752720000006, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

CD 1790

7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C25H27N7O3 (473.21752720000006)


CD 1790 is a metabolite of linagliptin. Linagliptin (BI-1356, trade names Tradjenta and Trajenta) is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly. (Wikipedia)

   

puberunine C

puberunine C

C23H36ClNO7 (473.21801760000005)


   

2-imino-10-methyl-N-[2-(4-morpholinyl)ethyl]-5-oxo-1-(3-pyridinylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide

2-imino-10-methyl-N-[2-(4-morpholinyl)ethyl]-5-oxo-1-(3-pyridinylmethyl)-3-dipyrido[3,4-c:1,2-f]pyrimidinecarboxamide

C25H27N7O3 (473.21752720000006)


   

Linagliptin Metabolite CD1790

Linagliptin Metabolite CD1790

C25H27N7O3 (473.21752720000006)